Skip to content
DataLookout
Menu

NCT04795193

MInithoraCotomy vs Sternotomy for Multivessel Coronary Artery Bypass Grafting: A Partially Randomized Patient Preference Trial Assessing Quality of Life and Patency Outcomes

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria shortened, about 12 words Show 6 more changesShow less
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    • Final enrollment: 180 participants (planned 248)
    • Primary completion date changed from estimate of Dec 31, 2025 to Jun 15, 2024
    • Study completion pushed from Dec 31, 2025 to Dec 31, 2029
    • Secondary endpoints: details revised at 8 of 28 entries
    • Study description expanded, about 246 words
  2. Notable Eligibility criteria expanded, about 35 wordsv3 Show 5 more changesShow less
    • Primary endpoints: 1 to 2
    • Enrollment target: 200 to 248
    • Secondary endpoints: 24 to 28
    • Study description expanded, about 18 words
    • Study title expanded, about 7 words
  3. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Primary and study completion dates pushed to Dec 31, 2025
    • Start date changed from estimate of Apr 2021 to Apr 15, 2021
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

SF-36 PCS score (Physical component summary of medical outcomes study-short form 36-item scores) at 30 days (1month) after surgery
Timeframe: 30 days (1 month) after surgery
Overall patency rate of the grafts
Timeframe: within 14 days after surgery (before discharge)

Secondary (28)

Perioperative transfusion volume
Incidence of cardiopulmonary bypass conversion
Percentage of intra-aortic balloon pump (IABP) and extracorporeal membrane oxygenation (ECMO) usage
Incidence of secondary surgery
Incidence of adverse events of wound healing
Show 23 moreShow less
Incidence of perioperative major adverse cardiovascular and cerebrovascular event (MACCE)
Incidence of atrial fibrillation
Incidence of renal failure
Incidence of re-intubation
Length of stay after surgery (days)
Intensive care unit (ICU) duration after surgery (hours)
Duration of mechanical ventilation application (hours)
Physical limitation score of Seattle angina questionnaire (SAQ)
Angina stability score of Seattle angina questionnaire (SAQ)
Angina frequency score of Seattle angina questionnaire (SAQ)
Treatment satisfaction score of Seattle angina questionnaire (SAQ)
Disease perception score of Seattle angina questionnaire (SAQ)
Time to the first major adverse cardiovascular and cerebrovascular event (MACCE) after surgery
Incidence of readmission due to myocardial infarction (MI)
Incidence of readmission due to heart failure
Percentage of mid-term graft patency (evaluated by CT or angiography)
SF-36 PCS scores
SF-36 MCS scores
Patency rate of the different material grafts
Bypass surgical variation index
Intrahospital RBC transfusion volume
Number of Participants with re-exploration for bleeding or other causes (not including wound-related causes)
Wound infection rate

Arms and interventions

MICS-CABG (minithoractomy CABG)Experimental

Patients undergoing MICS-CABG(minithoractomy CABG)

CABG (sterotomy CABG)Active comparator

Patients undergoing CABG (sterotomy CABG)

Procedures: Minimal invasive coronary surgery, Off-pump coronary artery bypass surgery

Sites

1 site in 1 country

  • Peking University Third HospitalBeijing, Beijing Municipality, China